Increased CD14<sup>+</sup>HLA-DR<sup>-/low</sup> myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome.

PeerJ · 2024 · PMC11468897 · PMID 39399429

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the difference in iNOS mRNA levels did not reach statistical significance, there was a trend towards increased iNOS expression in ACS patients.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Increased CD14&lt;sup&gt;+&lt;/sup&gt;HLA-DR&lt;sup&gt;-/low&lt;/sup&gt; myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome.

The sentences

Increased CD14<sup>+</sup>HLA-DR<sup>-/low</sup> myeloid-derived suppressor cells can be regarded as a biomarker on disease severity and response to therapy in acute coronary syndrome.